U.S. bill targets `bupe' limit

It aims to expand aid for heroin users

December 17, 2006|By John Fritze | John Fritze,[Sun reporter]

The number of heroin addicts receiving a revolutionary drug that is safer than methadone could triple under pending federal legislation -- a change that Baltimore health care advocates say could help the city combat addiction.

Physicians would be allowed to prescribe buprenorphine, commonly known as "bupe," to 100 patients -- up from the current 30-patient limit. Unlike methadone, bupe is taken at home and is less prone to abuse.

Easing buprenorphine regulations will boost an initiative crafted this year by City Hall to train more doctors to prescribe the drug. The effort could speed distribution of buprenorphine in a city long considered one of the most addicted in the nation.

"Whatever we're able to accomplish with our effort, this potentially triples the impact," said the city's health commissioner, Dr. Joshua Sharfstein.

About 1,000 people in Baltimore take buprenorphine, compared with about 4,500 who receive methadone every day, according to city estimates.

The Food and Drug Administration approved buprenorphine for opiate addiction in 2002 but regulated its distribution to discourage misuse. Congress requires doctors to receive eight hours of training and limits the number of patients they are permitted to treat with the drug.

The new legislation, part of the Office of National Drug Control Policy Reauthorization Act of 2006, was approved by Congress on Dec. 8. A White House spokeswoman said President Bush is reviewing the legislation.

"This gives us an opportunity to treat more people and to get them on their way to living a life where they are no longer addicted to heroin," said Rep. Elijah E. Cummings, who supported the bill. "All of this is an effort to heal our city."

One advantage of buprenorphine is that patients can be treated by a primary-care doctor rather than at a methadone clinic. The approach gives addicts who might not receive regular medical attention more frequent contact with a physician.

As part of the city's effort, drug treatment centers are getting addicts clean with buprenorphine and then referring them to family doctors.

"You can see the ravages that drug addiction has created in the city," said Adam B. Brickner, president and chief executive officer of Baltimore Substance Abuse Systems Inc., a nonprofit organization that oversees publicly funded drug treatment programs. "There's a lot of stigma around addiction still. Hopefully, we're slowly going to erode those and people will recognize that this is a medical condition."

In October, Sharfstein announced that Baltimore would train at least 100 more doctors to prescribe the drug. More than 40 doctors signed up for the training, but area hospitals have committed to send hundreds more through the program.

Howard County used private money to coordinate training last year, but only seven physicians signed up. National experts have said it is unusual for local governments to pick up the cost of training, and Baltimore's program appears to be considerably more ambitious than what has been attempted elsewhere.

Few, if any, primary care doctors will immediately pick up 100 patients. But Dr. Michael Fingerhood, an internist at Johns Hopkins Bayview Medical Center, said the higher cap allows doctors to treat more stable patients while taking on new ones.

Fingerhood has prescribed buprenorphine for three years along with four other doctors in his office. At least two are nearing the 30-patient limit.

"It certainly takes a lot of time and effort to do this right and I think we all want to make sure that we do this right," Fingerhood said. "But 30 was limiting."


To read previous articles about buprenorphine, go to baltimoresun.com/bupe

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.